Discover how commensal bacteria in cystic fibrosis airways protect against inflammation and could revolutionize treatment approaches.
Discover how Prevotella histicola manipulates Toll-like receptor signaling to reduce inflammation in cystic fibrosis lungs through alternative NF-κB pathway activation.
Discover how CFTR modulators like lumacaftor/ivacaftor transform the cystic fibrosis lung microbiome and metabolome, creating a less hospitable environment for pathogens.